anti-cytokine therapy for carpal tunnel syndrome

anti-cytokine therapy for carpal tunnel syndrome - anti-cytokine therapy for carpal tunnel syndrome

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016027

Enrollment

Registered

2014-12-22

Start date

2013-02-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carpal tunnel syndrome

Interventions

1.carpal tunnel injection of local anesthetic agent group 2.carpal tunnel injection of local anesthetic agent and anti-TNFa inhibitor group 3.carpal tunnel injection of local anesthetic agent and an

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.numbness and/or pain on fingers 2.electrodiagnostic tes can explain the condition 3.agreement with this study

Exclusion criteria

Exclusion criteria: 1.loss of consiousness 2.severe systemic complications

Design outcomes

Primary

Measure	Time frame
1. analgesic effect 2. adverse events	—

Countries

Japan

Contacts

Public ContactRei Abe

Chiba University Hospital Department of Orthopaedic Surgery

aberei@chiba-u.jp043-226-2117

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026